1. Home
  2. FOLD vs PECO Comparison

FOLD vs PECO Comparison

Compare FOLD & PECO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$14.30

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Logo Phillips Edison & Company Inc.

PECO

Phillips Edison & Company Inc.

HOLD

Current Price

$37.53

Market Cap

4.5B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOLD
PECO
Founded
2002
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
4.5B
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
FOLD
PECO
Price
$14.30
$37.53
Analyst Decision
Buy
Buy
Analyst Count
10
7
Target Price
$26.11
$38.71
AVG Volume (30 Days)
7.8M
870.6K
Earning Date
02-18-2026
02-05-2026
Dividend Yield
N/A
3.44%
EPS Growth
N/A
37.32
EPS
N/A
0.65
Revenue
$598,704,000.00
$711,781,000.00
Revenue This Year
$21.49
$10.46
Revenue Next Year
$18.46
$5.30
P/E Ratio
N/A
$57.92
Revenue Growth
21.28
10.73
52 Week Low
$5.51
$32.40
52 Week High
$14.38
$37.89

Technical Indicators

Market Signals
Indicator
FOLD
PECO
Relative Strength Index (RSI) 79.26 78.49
Support Level $14.30 $34.95
Resistance Level $14.31 $35.87
Average True Range (ATR) 0.03 0.65
MACD -0.13 0.29
Stochastic Oscillator 35.00 99.14

Price Performance

Historical Comparison
FOLD
PECO

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

About PECO Phillips Edison & Company Inc.

Phillips Edison & Co Inc is a real estate investment trust. The company also operates a third-party investment management business providing property management and advisory services to four unconsolidated institutional joint ventures, in which it has a partial ownership interests, and one private fund. It invests in well-occupied, grocery-anchored neighborhood and community shopping centers. It holds an integrated in-house operating platform built on market of expertise designed to optimize property value and consistently deliver a great shopping experience.

Share on Social Networks: